The activated pro-tumor MSCs can increase the production of soluble factors, including CCL-2 and TGF-β that regulate the immune responses in the primary tumor and facilitate the recruitment of monocytes and MDSCs to create the immunosuppressive tumor microenvironment 68, 69. Here, CCL2 is linked to neoplasm.